CRT 2016 Technology & Innovation - New Preclinical Findings that May Impact Outcome of Renal Denervation

Conference
A session outlining New Preclinical Findings that May Impact Outcome of Renal Denervation

Add this Moment to your Passport

Learn from this moment and keep it forever.
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Overview

CRT 2016 Technology & Innovation - New Preclinical Findings that May Impact Outcome of Renal Denervation

Session Moderators & Panelists: Krishna Rocha-Singh, MD, FSCAI; Robert Schwartz, MD, FSCAI; Horst Sievert, MD, FSCAI

4 Expert Sessions, plus a Roundtable Panel Discussion

Featuring

  • Krishna Rocha-Singh, MD, FSCAI
  • Robert Schwartz, MD, FSCAI
  • Horst Sievert, MD, FSCAI
  • Elena Ladich, MD
  • Abraham Tzafriri, PhD
  • Justin Davies, BSc, MBBS, PhD
  • Zorina Galis, PhD
  • Michael Joner, MD
  • Vasilios Papademetriou, MD, Dsc
  • Renu Virmani, MD

Add this Moment to your Passport

Learn from this moment and keep it forever.
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.



Target Audience

  • Interventional Cardiologists
  • Interventional Fellows
  • Physicians with an interest in Resistant Hypertension

Session Name: New Preclinical Findings that May Impact Outcome of Renal Denervation

Track: Technology & Innovation 

Learning Objectives

  • Updates in Renal Denervation and Hypertension Therapies

Loading Simple Education